×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [1]
Faculty of Healt... [1]
THE STATE KEY LA... [1]
Faculty of Scien... [1]
Authors
MOK SENG PENG [1]
WANG RUIBING [1]
Document Type
Journal article [1]
Date Issued
2023 [1]
Language
英語English [1]
Source Publication
Acta Biomaterial... [1]
Indexed By
SCIE [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-1 of 1
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Submit date Ascending
Submit date Descending
Hyaluronic acid-based supramolecular nanomedicine with optimized ratio of oxaliplatin/chlorin e6 for combined chemotherapy and O2-economized photodynamic therapy
Journal article
Ding,Yuan Fu, Xu,Xun, Li,Junyan, Wang,Ziyi, Luo,Jingwei, Mok,Greta S.P., Li,Shengke, Wang Ruibing. Hyaluronic acid-based supramolecular nanomedicine with optimized ratio of oxaliplatin/chlorin e6 for combined chemotherapy and O2-economized photodynamic therapy[J]. Acta Biomaterialia, 2023, 164, 397-406.
Authors:
Ding,Yuan Fu
;
Xu,Xun
;
Li,Junyan
;
Wang,Ziyi
;
Luo,Jingwei
; et al.
Favorite
|
TC[WOS]:
15
TC[Scopus]:
16
IF:
9.4
/
9.9
|
Submit date：2023/08/03
Cd44 Targeting
Combined Therapy
Host-guest Interaction
Hypoxia
Nanomedicine
